Sfoglia per Autore
DIFFERENT EXPRESSION OF E-CADERINE, BETA CATENIN AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL CARCINOMA.
2006-01-01 SANGUEDOLCE R; D CABIBI; L RAUSA; F FERRAU'; F ARAGONA; A MARTORANA; E BARRESI; A CALASCIBETTA
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast.
2006-01-01 BRANDI M; CALASCIBETTA A; CABIBI D; MARTORANA A; ARAGONA F; FULFARO F; VALERIO M; DISPENSA J; SANGUEDOLCE R
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophosphamide, methotrexate, 5-fluorouracil chemotherapy(CMF) versus docetaxel (TXT) in locally advanced carcinoma of the breast.
2006-01-01 M BRANDI; A CALASCIBETTA; D CABIBI; A MARTORANA; F ARAGONA; FULFARO F; M VALERIO; J DISPENZA; R SANGUEDOLCE
Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients.
2006-01-01 CALASCIBETTA A; CABIBI D; RAUSA L; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
Decreased expression of thymidylate synthase and low proliferation index assessed by ki67 in " signet ring cell component" of colorectal carcinomas
2006-01-01 CABIBI D; CALASCIBETTA A; CAMPIONE F; ARAGONA F; SANGUEDOLCE R
RELATIONSHIP BETWEEN THYMIDYLATE SYNTHASE EXPRESSION AND p53 LEVELS WITH THE TREATMENT BY CYCLOPHOSPHAMIDE, 5-FLUOROURACIL CHEMOTHERAPY (CMF) VERSUS DOCETAXEL IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST.
2006-01-01 M BRANDI; A CALASCIBETTA; D CABIBI; A MARTORANA; F ARAGONA; F FULFARO; M VALERIO; J DISPENZA; SANGUEDOLCE R
Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer
2006-01-01 CABIBI D; MUSTACCHIO V; MARTORANA A; TRIPODO C; CAMPIONE M; CALASCIBETTA A; SANGUEDOLCE R; ARAGONA F
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”.
2006-01-01 POMA P; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA M; SANGUEDOLCE R; ALAIMO A; CARINA V; MAURICI A; CUSIMANO A; CERVELLO M; D'ALESSANDRO N
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophsphamide, methotrexate, 5-fluorouracil chemotherapy ( CMF)versus docetaxel ( TXT) in locally advanced carcinoma of the breast
2006-01-01 BRANDI M; CALASCIBETTA A; CABIBI D; MARTORANA A; ARAGONA F; FULFARO M; VALERIO M; DISPENZA J; SANGUEDOLCE R
Difference in ki67 and Thimidylate Synthase expressin in primary tumour compared with metastatic nodes in breast cancer patients
2006-01-01 CALASCIBETTA A; CABIBI D; RAUSA L; ARAGONA F; BARRESI E; MARTORANA A; SANGUEDOLCE R
Different expression of e-cadherin, beta-catenin and fibronectin in signet ring cell, and intestinal colorectal carcinoma
2006-01-01 SANGUEDOLCE R; CABIBI D; RAUSA L; FEARRU F; ARAGONA F; MARTORANA A; BARRESI E; CALASCIBETTA A
Analysis of coding and non-coding regions of thymidylate syntetase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response
2007-01-01 CALASCIBETTA A; GULOTTA G; CAJOZZO M; FEO S; AGRUSA A; GANGUEDOLCE G; SANGUEDOLCE R
Analysis of the thymidylate syntethase gene structure in colorectal cancer patients, and its possible relation with the 5-fluoruracil drug response
2007-01-01 SANGUEDOLCE R; GULOTTA G; CAJOZZO M; AGRUSA A; FESO S; SANGUEDOLCE G; CALASCIBETTA A
Decreased expression of thymidylate synthase and low proliferation index by Ki67 in "signet ring cell component of colorectal carcinoma"
2007-01-01 D CABIBI; A CALASCIBETTA; M CAMPIONE; SANGUEDOLCE R
Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients.
2007-01-01 CABIBI D; CALASCIBETTA A; MARTORANA A; CAMPIONE M; BARRESI E; RAUSA L; ARAGONA F; SANGUEDOLCE R
Possible role of differential metalloproteinase 1 expression in signet ring cell and intestinal colorectal carcinoma histotypes
2008-01-01 R SANGUEDOLCE; D CABIBI; A MARTORANA; F ARAGONA; CALASCIBETTA A
Could a variant structural form of thymidylate synthase gene of metastatic colorectal cancer patients be related with the poor response to 5 Fu treatment?
2008-01-01 CALASCIBETTA A; GGULOTTA; G DIANA; G GUERCIO; G SANGUEDOLCE; R SANGUEDOLCE
Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma.
2009-01-01 Cabibi, D; Calascibetta, A; Aragona, F; Martorana, A; Campione, M; Sanguedolce, R
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients
2009-01-01 PROVENZANI ALESSIO; NOTARBARTOLO M; LABBOZZETTA M; POMA P; BIONDI F; SANGUEDOLCE R; VIZZINI G; PALAZZO U; POLIDORI P; TRIOLO F; GRIDELLI B; D'ALESSANDRO N
Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and lts Possible Relation with the S-Fluorouracil Drug Response
2010-01-01 Calascibetta, A; Contino, F; Feo, S; Gulotta, G; Cajozzo, M; Antona, A; Sanguedolce, G; Sanguedolce, R
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile